Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

Last updated: April 16, 2025
Sponsor: George Washington University
Overall Status: Active - Recruiting

Phase

3

Condition

N/A

Treatment

Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)

Intercostal nerve block

Clinical Study ID

NCT06810375
NCR246143
  • Ages 18-90
  • All Genders

Study Summary

This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Video assisted pulmonary resection, pleurodesis or decortication

Exclusion

Exclusion Criteria:

  • Allergy to local anesthetics

  • Patient undergoing bilateral surgery

  • Surgery is emergent as deemed by the principal investigator

Study Design

Total Participants: 120
Treatment Group(s): 2
Primary Treatment: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
Phase: 3
Study Start date:
March 01, 2025
Estimated Completion Date:
February 28, 2029

Connect with a study center

  • The George Washington University Hospital

    Washington, District of Columbia 20037
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.